The global market for 3D Microfluidic Organ Chip was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for 3D Microfluidic Organ Chip is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for 3D Microfluidic Organ Chip is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of 3D Microfluidic Organ Chip include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis, Micronit Microtechnologies B.V., Kirkstall, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for 3D Microfluidic Organ Chip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Microfluidic Organ Chip.
The 3D Microfluidic Organ Chip market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 3D Microfluidic Organ Chip market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D Microfluidic Organ Chip manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Others
by Application
Hospital
Biotechnology
Others
Production by Region
North America
Europe
China
Japan
South Korea
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 3D Microfluidic Organ Chip manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of 3D Microfluidic Organ Chip by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of 3D Microfluidic Organ Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 3D Microfluidic Organ Chip 麻豆原创 Overview
1.1 Product Definition
1.2 3D Microfluidic Organ Chip by Type
1.2.1 Global 3D Microfluidic Organ Chip 麻豆原创 Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Brain-on-a-chip
1.2.3 Liver-on-a-chip
1.2.4 Kidney-on-a-chip
1.2.5 Others
1.3 3D Microfluidic Organ Chip by Application
1.3.1 Global 3D Microfluidic Organ Chip 麻豆原创 Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Hospital
1.3.3 Biotechnology
1.3.4 Others
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global 3D Microfluidic Organ Chip Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global 3D Microfluidic Organ Chip Production Estimates and Forecasts (2020-2031)
1.4.4 Global 3D Microfluidic Organ Chip 麻豆原创 Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global 3D Microfluidic Organ Chip Production 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global 3D Microfluidic Organ Chip Production Value 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Key Players of 3D Microfluidic Organ Chip, Industry Ranking, 2023 VS 2024
2.4 Global 3D Microfluidic Organ Chip 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global 3D Microfluidic Organ Chip Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of 3D Microfluidic Organ Chip, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of 3D Microfluidic Organ Chip, Product Offered and Application
2.8 Global Key Manufacturers of 3D Microfluidic Organ Chip, Date of Enter into This Industry
2.9 3D Microfluidic Organ Chip 麻豆原创 Competitive Situation and Trends
2.9.1 3D Microfluidic Organ Chip 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest 3D Microfluidic Organ Chip Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 3D Microfluidic Organ Chip Production by Region
3.1 Global 3D Microfluidic Organ Chip Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global 3D Microfluidic Organ Chip Production Value by Region (2020-2031)
3.2.1 Global 3D Microfluidic Organ Chip Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of 3D Microfluidic Organ Chip by Region (2026-2031)
3.3 Global 3D Microfluidic Organ Chip Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global 3D Microfluidic Organ Chip Production Volume by Region (2020-2031)
3.4.1 Global 3D Microfluidic Organ Chip Production by Region (2020-2025)
3.4.2 Global Forecasted Production of 3D Microfluidic Organ Chip by Region (2026-2031)
3.5 Global 3D Microfluidic Organ Chip 麻豆原创 Price Analysis by Region (2020-2025)
3.6 Global 3D Microfluidic Organ Chip Production and Value, Year-over-Year Growth
3.6.1 North America 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2020-2031)
3.6.3 China 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2020-2031)
3.6.5 South Korea 3D Microfluidic Organ Chip Production Value Estimates and Forecasts (2020-2031)
4 3D Microfluidic Organ Chip Consumption by Region
4.1 Global 3D Microfluidic Organ Chip Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global 3D Microfluidic Organ Chip Consumption by Region (2020-2031)
4.2.1 Global 3D Microfluidic Organ Chip Consumption by Region (2020-2025)
4.2.2 Global 3D Microfluidic Organ Chip Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America 3D Microfluidic Organ Chip Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe 3D Microfluidic Organ Chip Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Netherlands
4.5 Asia Pacific
4.5.1 Asia Pacific 3D Microfluidic Organ Chip Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific 3D Microfluidic Organ Chip Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa 3D Microfluidic Organ Chip Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa 3D Microfluidic Organ Chip Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Israel
5 Segment by Type
5.1 Global 3D Microfluidic Organ Chip Production by Type (2020-2031)
5.1.1 Global 3D Microfluidic Organ Chip Production by Type (2020-2025)
5.1.2 Global 3D Microfluidic Organ Chip Production by Type (2026-2031)
5.1.3 Global 3D Microfluidic Organ Chip Production 麻豆原创 Share by Type (2020-2031)
5.2 Global 3D Microfluidic Organ Chip Production Value by Type (2020-2031)
5.2.1 Global 3D Microfluidic Organ Chip Production Value by Type (2020-2025)
5.2.2 Global 3D Microfluidic Organ Chip Production Value by Type (2026-2031)
5.2.3 Global 3D Microfluidic Organ Chip Production Value 麻豆原创 Share by Type (2020-2031)
5.3 Global 3D Microfluidic Organ Chip Price by Type (2020-2031)
6 Segment by Application
6.1 Global 3D Microfluidic Organ Chip Production by Application (2020-2031)
6.1.1 Global 3D Microfluidic Organ Chip Production by Application (2020-2025)
6.1.2 Global 3D Microfluidic Organ Chip Production by Application (2026-2031)
6.1.3 Global 3D Microfluidic Organ Chip Production 麻豆原创 Share by Application (2020-2031)
6.2 Global 3D Microfluidic Organ Chip Production Value by Application (2020-2031)
6.2.1 Global 3D Microfluidic Organ Chip Production Value by Application (2020-2025)
6.2.2 Global 3D Microfluidic Organ Chip Production Value by Application (2026-2031)
6.2.3 Global 3D Microfluidic Organ Chip Production Value 麻豆原创 Share by Application (2020-2031)
6.3 Global 3D Microfluidic Organ Chip Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Emulate
7.1.1 Emulate 3D Microfluidic Organ Chip Company Information
7.1.2 Emulate 3D Microfluidic Organ Chip Product Portfolio
7.1.3 Emulate 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Emulate Main Business and 麻豆原创s Served
7.1.5 Emulate Recent Developments/Updates
7.2 TissUse
7.2.1 TissUse 3D Microfluidic Organ Chip Company Information
7.2.2 TissUse 3D Microfluidic Organ Chip Product Portfolio
7.2.3 TissUse 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2020-2025)
7.2.4 TissUse Main Business and 麻豆原创s Served
7.2.5 TissUse Recent Developments/Updates
7.3 Hesperos
7.3.1 Hesperos 3D Microfluidic Organ Chip Company Information
7.3.2 Hesperos 3D Microfluidic Organ Chip Product Portfolio
7.3.3 Hesperos 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Hesperos Main Business and 麻豆原创s Served
7.3.5 Hesperos Recent Developments/Updates
7.4 CN Bio Innovations
7.4.1 CN Bio Innovations 3D Microfluidic Organ Chip Company Information
7.4.2 CN Bio Innovations 3D Microfluidic Organ Chip Product Portfolio
7.4.3 CN Bio Innovations 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2020-2025)
7.4.4 CN Bio Innovations Main Business and 麻豆原创s Served
7.4.5 CN Bio Innovations Recent Developments/Updates
7.5 Tara Biosystems
7.5.1 Tara Biosystems 3D Microfluidic Organ Chip Company Information
7.5.2 Tara Biosystems 3D Microfluidic Organ Chip Product Portfolio
7.5.3 Tara Biosystems 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Tara Biosystems Main Business and 麻豆原创s Served
7.5.5 Tara Biosystems Recent Developments/Updates
7.6 Draper Laboratory
7.6.1 Draper Laboratory 3D Microfluidic Organ Chip Company Information
7.6.2 Draper Laboratory 3D Microfluidic Organ Chip Product Portfolio
7.6.3 Draper Laboratory 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Draper Laboratory Main Business and 麻豆原创s Served
7.6.5 Draper Laboratory Recent Developments/Updates
7.7 Mimetas
7.7.1 Mimetas 3D Microfluidic Organ Chip Company Information
7.7.2 Mimetas 3D Microfluidic Organ Chip Product Portfolio
7.7.3 Mimetas 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Mimetas Main Business and 麻豆原创s Served
7.7.5 Mimetas Recent Developments/Updates
7.8 Nortis
7.8.1 Nortis 3D Microfluidic Organ Chip Company Information
7.8.2 Nortis 3D Microfluidic Organ Chip Product Portfolio
7.8.3 Nortis 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Nortis Main Business and 麻豆原创s Served
7.8.5 Nortis Recent Developments/Updates
7.9 Micronit Microtechnologies B.V.
7.9.1 Micronit Microtechnologies B.V. 3D Microfluidic Organ Chip Company Information
7.9.2 Micronit Microtechnologies B.V. 3D Microfluidic Organ Chip Product Portfolio
7.9.3 Micronit Microtechnologies B.V. 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Micronit Microtechnologies B.V. Main Business and 麻豆原创s Served
7.9.5 Micronit Microtechnologies B.V. Recent Developments/Updates
7.10 Kirkstall
7.10.1 Kirkstall 3D Microfluidic Organ Chip Company Information
7.10.2 Kirkstall 3D Microfluidic Organ Chip Product Portfolio
7.10.3 Kirkstall 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Kirkstall Main Business and 麻豆原创s Served
7.10.5 Kirkstall Recent Developments/Updates
7.11 Cherry Biotech SAS
7.11.1 Cherry Biotech SAS 3D Microfluidic Organ Chip Company Information
7.11.2 Cherry Biotech SAS 3D Microfluidic Organ Chip Product Portfolio
7.11.3 Cherry Biotech SAS 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Cherry Biotech SAS Main Business and 麻豆原创s Served
7.11.5 Cherry Biotech SAS Recent Developments/Updates
7.12 Else Kooi Laboratory
7.12.1 Else Kooi Laboratory 3D Microfluidic Organ Chip Company Information
7.12.2 Else Kooi Laboratory 3D Microfluidic Organ Chip Product Portfolio
7.12.3 Else Kooi Laboratory 3D Microfluidic Organ Chip Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Else Kooi Laboratory Main Business and 麻豆原创s Served
7.12.5 Else Kooi Laboratory Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 3D Microfluidic Organ Chip Industry Chain Analysis
8.2 3D Microfluidic Organ Chip Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 3D Microfluidic Organ Chip Production Mode & Process Analysis
8.4 3D Microfluidic Organ Chip Sales and 麻豆原创ing
8.4.1 3D Microfluidic Organ Chip Sales Channels
8.4.2 3D Microfluidic Organ Chip Distributors
8.5 3D Microfluidic Organ Chip Customer Analysis
9 3D Microfluidic Organ Chip 麻豆原创 Dynamics
9.1 3D Microfluidic Organ Chip Industry Trends
9.2 3D Microfluidic Organ Chip 麻豆原创 Drivers
9.3 3D Microfluidic Organ Chip 麻豆原创 Challenges
9.4 3D Microfluidic Organ Chip 麻豆原创 Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
听
听
*If Applicable.
